NEUROFARBA Department, University of Florence, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Italy.
Department of Chemistry, COMSATS University Islamabad Abbottabad Campus, 22060, Abbottabad, Pakistan.
ChemMedChem. 2020 Dec 15;15(24):2444-2447. doi: 10.1002/cmdc.202000680. Epub 2020 Oct 28.
A series of benzylaminoethylureido-tailed benzenesulfonamides was analyzed for their inhibition potential against bacterial carbonic anhydrases (CAs) such as VhCA α, β, and γ from Vibrio cholerae, and BpsCA β and γ-CAs from Burkholderia pseudomallei. Growing drug resistance against antibiotics demands alternative targets and mechanisms of action. As CA is essential for the survival of bacteria, such enzymes have the potential for developing new antibiotics. Most of the compounds presented excellent inhibition potential against VhCA γ compared to α and β, with K values in the range of 82.5-191.4 nM. Several sulfonamides exhibited excellent inhibition against BpsCA β with K values in the range of 394-742.8 nM. Recently it has been demonstrated that sufonamide CA inhibitors are effective against vancomycin-resistant enterococci. These data show that CA inhibition of pathogenic bacteria may lead to a new class of antibiotics.
一系列苄氨基乙撑脲基苯磺酰胺类化合物被分析其对细菌碳酸酐酶(CA)的抑制潜力,如霍乱弧菌的 VhCAα、β 和γ,以及伯克霍尔德菌的 BpsCAβ 和γ-CA。抗生素耐药性的不断增加要求寻找替代的靶标和作用机制。由于 CA 是细菌生存所必需的,因此这些酶具有开发新型抗生素的潜力。与 VhCAα 和β 相比,大多数化合物对 VhCAγ 表现出优异的抑制潜力,K 值范围在 82.5-191.4nM 之间。一些磺胺类化合物对 BpsCAβ 表现出优异的抑制作用,K 值范围在 394-742.8nM 之间。最近已经证明,磺胺 CA 抑制剂对万古霉素耐药肠球菌有效。这些数据表明,抑制病原菌的 CA 可能会产生一类新的抗生素。